Skin Clearance, Treatment Response Off-therapy, and Safety of Tapinarof Cream 1% Once Daily: Results from ADORING 3, a 48-week Phase 3 Trial in Adults and Children Down to 2 Years of Age with Atopic Dermatitis. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 8, n. 6, p. s460, 2024. DOI: 10.25251/skin.8.supp.460. Disponível em: https://skin.dermsquared.com/skin/article/view/3111. Acesso em: 13 jun. 2025.